<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04282096</url>
  </required_header>
  <id_info>
    <org_study_id>ID RCB 2017-A03192-51</org_study_id>
    <secondary_id>CRNH 2017-4</secondary_id>
    <nct_id>NCT04282096</nct_id>
  </id_info>
  <brief_title>Nutritional Caracterisation of Micellar Casein</brief_title>
  <official_title>Nutritional Caracterisation of Micellar Casein</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ingredia S.A.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ingredia S.A.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are different types of casein on the market, which differ according to their chemical
      or physical process of obtaining. The processes will impact structural differences in the
      macromolecular assembly.

      The majority of caseins marketed in nutrition are casein in the form of Na caseinate or Ca
      caseinate.

      The micellar caseins obtained by membrane filtration (physical process) are more and more
      used in the nutrition market.

      The development of casein extraction with different structures on an industrial scale opens
      up other perspectives for these proteins, particularly in terms of health.

      The main objective of this project is to study the postprandial kinetics of the plasma
      concentrations of the essential amino acids of three structurally different types of caseins.

      The secondary objective is to study the speed of gastric emptying and the nutritional
      properties of different proteins.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All the participants will give freely their written informed consent before their selection
      in the study.

      Each subject will participate in 3 kinetics of 5 hours with a different product test each
      time, in a randomized order. A wash-out period of at least 7 days will be respected between
      each kinetics. The products to be tested will be in the form of a powder (25g individual
      sachet, including 20.1g of protein) which will be reconstituted in 250ml of water and to
      which 100mg of 13C sodium acetate will be added.

      For each of the kinetics, blood samples, expires gasses, will be collected at different time
      during the kinetics. A urinary collection throughout the day of kinetics will also be
      performed to allow the determination of urinary nitrogen Indirect calorimetry measurements
      will be performed 45 minutes every hour in the postprandial period and a measurement of 45
      minutes will be made when the subject is fasting. Six measurements of indirect calorimetry
      will be performed for each kinetic.

      Finally subjects will be asked to evaluate their satiety on a visual analog scale, 15' before
      taking the product, then every 15' the first hour in the postprandial period and every 30
      'from the 2nd hour.

      The subjects will also have a tolerance questionnaire to complete with each kinetic.

      At the end of the kinetics, a standardized meal, single menu, consumption ad libitum measured
      in double weighing will be proposed to the volunteers to evaluate their satiety

      During the 3 days preceding each kinetics, the protein intake of the subjects will be
      controlled. The meal of each night in the evening of kinetics will be standardized and
      identical for each kinetics. The volunteers will complete a food survey on the 3 days of
      control of their diet that precede each kinetics.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 23, 2018</start_date>
  <completion_date type="Actual">November 5, 2018</completion_date>
  <primary_completion_date type="Actual">October 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>double blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in the plasma concentrations of the essential amino acids of 3 structurally different types of caseins during postprandial kinetics</measure>
    <time_frame>before and during 300 minutes after product consumption</time_frame>
    <description>Maximum total plasma concentration of the essential amino acids measured during different points of the 5 hours of the kinetics (one kinetic / type of casein). One point before (basal) and several points (15, 30, 45, 60, 90, 120, 150, 180, 210, 240, 270, 300 minutes) after the consumption of one of the 3 types of caseins</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maximum plasma concentration for non essential amino acids</measure>
    <time_frame>before and during 300 minutes after product consumption</time_frame>
    <description>Maximum total plasma concentration of the non essential amino acids measured during different points of the 5 hours of the kinetics (one kinetic / type of casein). One point before (basal) and several points (15, 30, 45, 60, 90, 120, 150, 180, 210, 240, 270, 300 minutes) after the consumption of one of the 3 types of caseins</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tmax</measure>
    <time_frame>before and during 300 minutes after product consumption</time_frame>
    <description>Time in minutes to obtain the maximal total plasma concentration of essential amino acides</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of gastric emptying by the 13C sodium acetate method</measure>
    <time_frame>before and during 300 minutes after product consumption</time_frame>
    <description>Time to obtain the maximum expired 13CO2 concentration (Tmax)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>gastric emptying at 50% (T 1/2)</measure>
    <time_frame>before and during 300 minutes after product consumption</time_frame>
    <description>Obtaining time for gastric emptying at 50% (T 1/2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thermogenic effect of proteins at different times of kinetics</measure>
    <time_frame>before and during 300 minutes after product consumption</time_frame>
    <description>Oxidation of substrates (lipids, proteins, carbohydrates) (g/min) by indirect respiratory calorimetry corrected for nitrogen excretion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satietogenic effect of proteins evaluated using a visual analogue scale at different times of kinetics</measure>
    <time_frame>from product consumption until 300 minutes after</time_frame>
    <description>Measured by a visual analogue scale 100mm in length with words anchored at each end, expressing the most positive and the most negative rating, were used to assess hunger, satiety, fullness, prospective food consumption.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerance of products assessed by a questionnaire</measure>
    <time_frame>at 300 minutes after product consumption</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the plasma concentrations of insulin at different times of kinetics</measure>
    <time_frame>before and during 300 minutes after product consumption</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Protein Digestion</condition>
  <arm_group>
    <arm_group_label>Caseine micellar</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sodium Casein</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Calcium casein</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>native and non native casein</intervention_name>
    <description>selected participant will test the 3 treatments in a random order</description>
    <arm_group_label>Calcium casein</arm_group_label>
    <arm_group_label>Caseine micellar</arm_group_label>
    <arm_group_label>Sodium Casein</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  - Aged 20 to 40 years

          -  BMI : 18.5-30 Kg/m2

          -  Healthy (apparently free of diseases)

          -  Without dietary supplement the last month

          -  Without allergy, lactose intolerance or aversion for milk protein

          -  Moderately physically active

          -  Affiliated to National Health Insurance

          -  Having provided her written informed consent

        Exclusion Criteria:

          -  Following any kind of treatment

          -  Smokers (&gt;5 cigarets/d)

          -  Vegetarian, vegan

          -  Individual unable to give informed consent or refusing to sign informed consent

          -  Being in exclusion on the National Volunteers Data file or refusing to be registered
             on the National Volunteers Data file

          -  Currently participating or who having got 4500â‚¬ in this year before to have
             participating in another clinical trial
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre de Recherche en Nutrition Humaine</name>
      <address>
        <city>Clermont Ferrand</city>
        <zip>63009</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>November 6, 2018</study_first_submitted>
  <study_first_submitted_qc>February 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 24, 2020</study_first_posted>
  <last_update_submitted>February 20, 2020</last_update_submitted>
  <last_update_submitted_qc>February 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre de Recherche en Nutrition Humaine d'Auvergne</investigator_affiliation>
    <investigator_full_name>Pr Ruddy Richard</investigator_full_name>
    <investigator_title>Professor, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Micellar casein</keyword>
  <keyword>Bioavailibility</keyword>
  <keyword>Gastric emptying</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Caseins</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

